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ABSTRACT
A 22-year-old female patient sought medical care due to an asymptomatic solid nodule in the liver,
incidentally diagnosed by abdominal ultrasound. She reported the use of an estrogen-based oral contra-
ceptive for approximately 3 years. She denied smoking or alcohol drinking. Her mother had a history of
nonalcoholic steato-hepatitis and her maternal grandmother had a hepatic hemangioma. Physical ex-
amination revealed an asymptomatic patient with discretely painful palpation of the right hypochondrium
close to the xiphoid appendix. Ultrasound examination revealed a 5.9 x 4.1 cm hypoechogenic nodule in
the left lobule and computed tomography revealed a 5.3 x 6.3 x 4.5 cm focal lesion in the 2/3 segments.
Other tests of hepatic function proved to be normal, except for serum gammaglutamyl transferase, which
was increased by approximately two times the mean reference value. With a diagnosis of focal nodular
hyperplasia, she was submitted to exploratory laparotomy followed by partial hepatectomy (segment III,
Figure 1). With a macroscopic diagnosis of hepatic adenoma, the anatomopathological report was focal
nodular hyperplasia. At present, after four years of postoperative follow-up, the patient is well and is
taking progesterone instead of the estrogen-based anovulatory agent.
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Introduction
Cavernous hemangiomas, tumors of blood ves-
sels, are the most common benign hepatic lesions. They
occur as soft blue-red nodules, usually single, individu-
alized, smaller than 2 cm, and located below  Glisson's
capsule.
Focal nodular hyperplasia (FNH) mainly occurs
among young women up to the third and fourth dec-
ades of life and consists of a lesion of well demar-
cated mass, encapsulated, usually yellow in color and
lighter than surrounding hepatic tissue. A typical pat-
tern of FNH presentation is a scar containing large
arterial vessels that exhibit fibromuscular hyperplasia.
This scar is depressed, central and interspersed with
fibrous septa containing intense proliferation of bile
ducts along its margin and an expressive lymphocyte
infiltrate that irradiate towards the periphery.
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Hepatic adenomas, benign hepatocyte neopla-
sias, also occur among young women in association
with the use of estrogen-based contraceptives. They
appear as pale well demarcated nodules which can be
found throughout the liver parenchyma. They are
bronze in color and are often colored with bile. Con-
sisting of laminae and cell cords without expressive
atypy showing variations both in size and in nucleus,
they sometimes present a lighter cytoplasm due to the
abundant presence of glycogen. When their location
issubcapsular, they tend to rupture, usually during preg-
nancy, due to the action of estrogen.1
We report here the case of a patient with a he-
patic nodule submitted to surgical treatment.
Case report
A 22-year-old female patient from Limeira, São
Paulo, sought medical care due to an asymptomatic
solid nodule in the liver incidentally diagnosed by ab-
dominal ultrasound (US).  She reported the use of an
estrogen-based oral contraceptive for approximately
3 years. She denied smoking or alcohol drinking or the
use of illicit drugs. Her mother had a history of nonal-
coholic steato-hepatitis and her maternal grandmother
had a hepatic hemangioma. She denied other gastroin-
testinal neoplasias in the family. Physical examination
revealed an symptomatic patient with discretely pain-
ful palpation of the right hypochondrium close to the
xiphoid appendix.
At admission, the patient brought a US exam in
which a hypoechogenic nodule was visible in the left
lateral segment, measuring 5.9 x 4.1, and a computed
axial tomography  showing a focal lesion in the left
lateral segment measuring 5.3 x 6.3 x 4.5 cm compat-
ible with FNH but also possibly representing a hepatic
adenoma (Figure 1).
Biochemical blood exams were normal, with a
discrete elevation of gamma glutamyltransferase (99
U/L; normal levels: 5 to 55 U/L). Serologic tests for
hepatitis B and C were negative. With a preoperative
diagnosis of FNH or possible hepatic adenoma, the
patient was then submitted to exploratory laparotomy
and to partial hepatectomy (segment III, Figure 2) by
Chevron incision.
Figure 1: Computed axial tomography with a hepatic nodule in segment 2 of the liver (arrow).
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The surgical finding was a liver with a hard-
ened lesion between segments II and III (Figure 2),
with no distant lesions and with the remaining liver
showing the habitual wine-colored aspect.
Anatomopathological analysis revealed macro-
scopically an oval, well-delimited and encapsulated
lesion measuring 5.5 x 5.0 x 3.3 cm white-yellowish in
color, lobulated, elastic, subcapsular and close to the
raw margin of surgical resection, as can be seen in
Figure 3. Histological sections revealed an encapsu-
lated, well-delimited nodular structure filled with nod-
ules of hepatic tissue intermingled with thick and in-
complete fibrous septa, with the latter showing bile
ducts as well as dilated vessels with thickened or
thinned walls. The hepatocytes inside the nodules were
of normal to slightly enlarged size, with the nuclei
showing no atypy. The perilesional hepatic tissue ex-
hibited preserved architecture and mild cholestasis. On
this basis, a diagnosis of FNH was determined, with a
resection margin close to the lesion (figures 4 and 5).
Figure 2: operated liver: LF- falciform ligament  C- raw resection area with
fulguration with an electric surgical knife ; S2- segment 2.
 
LF 
C 
S2 
Figure 3: Surgical specimen with a hepatic nodule (arrow) in the resected segment.
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Figure 4: Histological aspect of the hepatic lesion. Hematoxylin-Eosin 40X - Panoramic view showing a band of fibrosis with prominent
vessels in the midst of hepatocellular proliferation without atypy (Panel A). Masson Trichrome 25X - Panoramic view showing structures
of the portal space type, with collagen staining green (Panel B)
Figure 5: Histological aspect of the hepatic lesion. Hematoxylin-Eosin 100X – Enlarged view showing prominent and irregular blood
vessels in the midst of fibrosis and areas containing hepatocyte trabeculae without atypy (Panel A). HE 200X – Enlarged view showing
blood vessels and proliferated bile ducts in the midst of hepatocyte trabeculae without atypy (Panel B).
The immediate surgical evolution of the patient
was good, without intercurrences; the surgical wound
was dry and clean and drains, nasogastric tube and
central access were removed early, with the patient
being discharged from the hospital, with a free return.
The patient returned after 2 years, asympto-
matic. In the subsequent year, 2010, hepatic function
exams were normal and magnetic resonance imaging
showed a suspicion of FNH in segment VII, which
was ruled out after discussion with the radiology team.
The patient was counseled to use progesterone-based
contraception.
Discussion
FNH is the second most common benign he-
patic tumor, corresponding to approximately 66 to 86%
of these benign tumors. In relation to primary hepatic
tumors, it corresponds to 8%,2 with its incidence be-
ing only lower than that of hepatic hemangiomas that
affect approximately 20% of the population3. In the
case of hepatocellular adenomas, the incidence of
these benign tumors showed an expressive increase
with the introduction of contraceptives, with the cur-
rent estimate being 34/100,000 women taking contra-
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ceptives.5 The risk is higher for women older than 30
years and  taking high doses of estrogen-based con-
traceptives for more than 5 years.4
The incidence of these three types of benign
neoplastic lesions is higher among women. Hemangi-
omas are more frequent among women aged 30 to 40
years and among neonates. FNH is more prevalent
among women of fertile age, i.e., 8 women: 1 man.5
Another similarity among these benign lesions
is that affected patients usually are asymptomatic and
the tumor is detected incidentally during indirect
imaging exams or at autopsy. 6
Symptoms that may occasionally occur are liver
tumoration and pain. Pain occurs when there is rup-
ture or hemorrhage of the nodule, a more frequent
situation among women using estrogen-based oral
contraceptives or during pregnancy, when women are
under estrogen stimulation.1 Laboratory tests usually
show no changes.
The influence of sex hormones such as estrogen
present in oral contraceptives on the pathogenesis of
hepatic adenomas has been demonstrated in the sci-
entific literature5,7,8, but their role in FNH is still de-
batable and has not been fully clarified.   It is believed
that there may be an association between the use of
these contraceptives and FNH, in which the use of
these agents would accelerate tumor growth. In some
patients, after discontinuation of an oral contraceptive
there was a spontaneous regression of FNH; how-
ever oral contraceptives do not seem to be the cause
of the lesion since cases of FNH have been observed
in children, men, women who never took contracep-
tives, and in some patients before the introduction of
the hormones.9
In contrast to adenomas, FNH is not a prema-
lignant lesion.2 On this basis, removal of the tumor is
indicated only in rare conditions such as cases of com-
plications (rupture or hemorrhage), or when tumors
are larger than 8 cm. Under other conditions, the treat-
ment indicated for FNH is tumor embolization by ar-
teriography or simply a conservative conduct with
periodic clinical follow-up. However, since adenomas
have a carcinogenic potential and a high risk of rup-
ture, surgical treatment is the direct indication regard-
less of the size of the lesion. In addition, in situations
of doubtful diagnosis, as in the present case, the op-
tion is for surgical treatment, as done here.
Although a relationship between the use of oral
contraceptives and FNH has not been confirmed, in
the present case we took into consideration the fol-
lowing factors:
1- The history of the development of a neoplasia
2-  The fertile age of the patient, with the possibility of
her getting pregnant (a risk factor for the rupture
of adenomas)
3- The relation between the use of estrogen and ad-
enomas
Thus, in the present case contraceptive therapy
based on progesterone was recommended since no
literature reports were found showing an association
between progesterone and hepatic tumors.
RESUMO
Paciente do sexo feminino, 22 anos, procurou auxílio médico devido a um nódulo sólido no fígado,
assintomático, diagnosticado incidentalmente por ultrassonografia de abdome.Relatava uso de anti-
concepcional oral, à base de estrógeno, por cerca de 3 anos. Negava tabagismo e etilismo. Mãe apre-
sentava história de esteato-hepatite não alcoólica e avó materna era portadora de hemangioma hepá-
tico. Ao exame físico, apresentava-se assintomática, com palpação discretamente dolorosa do
hipocôndrio direito próximo ao apêndice xifóide. Ao exame ultrasonográfico apresentava um nódulo
hipoecogênico no lóbulo esquerdo de 5,9 x 4,1 cm e à tomografia computadorizada apresentava lesão
focal nos segmentos 2/3 de 5,3 x 6,3 x 4,5 cm. Foram colhidos outros exames representativos da função
hepática, que se revelaram normais com exceção da gama glutamiltransferase sérica, que apresenta-
va-se aumentada aproximadamente duas vezes o valor médio de referência.Com diagnóstico de
hiperplasia nodular focal foi submetida à laparotomia exploradora e realizada hepatectomia parcial
(segmento III, figura 1). Com diagnóstico macroscópico de adenoma hepático, o laudo anatomopatológico
foi hiperplasia nodular focal.Atualmente, com quatro anos de acompanhamento pós-operatório encon-
tra-se bem, tendo sido feita substituição do anovulatório à base de estrógeno por progesterona
Palavras-Chave: Fígado. Hiperplasia nodular focal. Estrógeno. Anovulatório. Progesterona.
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